版本:
中国

BRIEF-Adaptimmune Q1 loss per share $0.05

May 10 Adaptimmune Therapeutics Plc

* Adaptimmune reports first quarter 2017 financial results

* Q1 revenue $2.9 million

* Q1 revenue view $4.9 million -- Thomson Reuters I/B/E/S

* Adaptimmune therapeutics plc - offerings in march and april raised net proceeds of $103.2 million; operations funded through to late 2019

* Q1 loss per share $0.05 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐